variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
PEX1-I696M,PEX1,"Reported as a mutation causing peroxisome biogenesis disorder in a single patient, presumably in a recessive manner.",High,Uncertain,Pathogenic,0.027,Metabolism,Recessive,Heterozygous,11389485,rs35996821,5,chr7,92132493,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
APC-E1317Q,APC,"This rare variant has been hypothesized to increase risk of colon cancer. Later studies have contradicted this, finding no significant enrichment and concluding the variant does not increase risk.",Moderate,Uncertain,Pathogenic,0.0088,Cancer,Dominant,Heterozygous,11001924;14578138;17119068,rs1801166,3,chr5,112175240,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
KRT5-G138E,KRT5,"This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",Low,Likely,Pathogenic,0.052,Cancer;Skin,Unknown,Heterozygous,19578363,rs11170164,3,chr12,52913668,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Homozygous,,rs2228527,0,chr10,50678369,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
KCNE2-T8A,KCNE2,"Found in about 1% of individuals, probably has no clinically significant effect. One group proposed that this variant may cause increased susceptibility to drug-induced arrhythmia, but this conclusion is not supported (and perhaps slightly contradicted) by their reported observations of the variant in clinical cases.",Low,Uncertain,Pharmacogenetic,0.0045,Drug response;Heart and circulatory,Dominant,Heterozygous,10984545,rs2234916,2,chr21,35742799,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
CCR5-S185Shift,CCR5,"Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.",Low,Well-established,Protective,0.048,Immune system,Recessive,Heterozygous,8751444;8791590;8898752,rs333,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Homozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Homozygous,19686598,rs3209986,,chr16,2140554,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Heterozygous,11292664,rs34221241,,chr5,180057293,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
RYR2-G1885E,RYR2,"Hypothesized to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1886S. However, this variant is quite common (2.4% in Europeans), as is G1886S (3.1% in Europeans), and about 1 in 700 are compound heterozygous. This is highly discordant with a disease prevalence of 1 in 2500 to 5000, and notably G1886S is reported in ClinVar as benign. We should consider the original hypothesis disproven.",Low,Likely,Benign,0.018,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Recessive,Heterozygous,16769042;18326664,rs41315858,0,chr1,237778082,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Homozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Homozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
PCCA-I475V,PCCA,"Reported as a polymorphism, tentatively presumed benign.",Low,Uncertain,Benign,0.038,Other,Unknown,Heterozygous,10101253,rs35719359,,chr13,100962156,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
F5-D2222G,F5,"Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.",Low,Uncertain,Benign,0.045,Blood,Unknown,Heterozygous,,rs6027,,chr1,169483561,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
ABCC11-G180R,ABCC11,This variant is associated with dry type ear wax (a benign trait) in a recessive manner.,Low,Uncertain,Benign,0.098,Other,Unknown,Heterozygous,14471313;16444273,rs17822931,,chr16,48258198,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
F5-M413T,F5,Presumed benign. This variant is not particularly rare and has not been reported to cause disease.,Low,Uncertain,Benign,0.058,Other,Unknown,Heterozygous,17284699,rs6033,,chr1,169521853,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Homozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f9be6cd6b36795b0ec0c93727e9ebf5083bc1a88&access_token=fc4dda6325058d258b4cfaa372aafd82
